Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

RSLS ReShape Lifesciences Inc

0,3663

-0,0137 (-3,61%)

26 Apr 2025 - Geschlossen

Verzögert um 15 Minuten

Form 424B3 - Prospectus [Rule 424(b)(3)]

Article too big to display. Click here to view on the SEC website

ReShape Lifesciences (NASDAQ:RSLS)
Historical Stock Chart
Von Mär 2025 bis Apr 2025

Click Here for more ReShape Lifesciences Charts.

ReShape Lifesciences (NASDAQ:RSLS)
Historical Stock Chart
Von Apr 2024 bis Apr 2025

Click Here for more ReShape Lifesciences Charts.

News ReShape Lifesciences Inc

Form 425 - Prospectuses and communications, business combinations
Montag 21 April 2025 (4 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 21 April 2025 (4 Tage vor) • Edgar (US Regulatory)

ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
Montag 21 April 2025 (5 Tage vor) • GlobeNewswire Inc.

ReShape Lifesciences® Partners with Motion Informatics to Bring AI-Driven Neurorehabilitation Technology to the U.S. Market
Mittwoch 9 April 2025 (2 Wochen vor) • GlobeNewswire Inc.

ReShape Lifesciences® Reports Year Ended December 31, 2024 Financial Results and Provides Corporate Update
Montag 7 April 2025 (3 Wochen vor) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Freitag 4 April 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Freitag 4 April 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 2 April 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
Dienstag 1 April 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 20 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Freitag 14 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Form PRER14A - Preliminary Proxy Soliciting materials
Donnerstag 13 März 2025 (1 Monat vor) • Edgar (US Regulatory)

Weitere ReShape Lifesciences Inc News-Artikel

Deutsche Telekom

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen